EDGAR Filing Documents for 0001104659-22-116479

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001104659-22-116479

Filing Date

2022-11-09

Accepted

2022-11-09 16:11:49

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	tm2230112d1_424b3.htm	424B3	449186
	Complete submission text file	0001104659-22-116479.txt		450353

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 424B3 | Act: 33 | File No.: 333-267840 | Film No.: 221372699
SIC: 2834 Pharmaceutical Preparations